시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 정량 흡입기 시장 보고서(2025년)
Metered Dose Inhaler Devices Global Market Report 2025
상품코드 : 1717230
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,242,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,023,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,803,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

정량 흡입기 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 당뇨병의 이환율 증가, 호흡기 질환 증가로 인한 가능성이 있습니다. 예측 기간에 예상되는 주요 동향에는 기술 개발, 혁신적인 치료법 개발, 규제 당국 승인, 새로운 흡입기 도입, 온라인 마케팅 도구의 보급 등이 포함됩니다.

만성 폐색성 폐 질환(COPD)의 유병률 증가는 정량 흡입기(MDI) 시장의 확대를 촉진할 것으로 예측됩니다. COPD는 공기 흐름 제한으로 특징지어지는 진행성 폐 질환으로, 일반적으로 담배 연기와 같은 자극 물질에 장시간 노출되어 발생하며 호흡 곤란, 기침, 천명음과 같은 증상을 유발합니다. MDI 장치는 폐에 직접 약물을 공급하고 신속한 완화를 제공하여 기류를 개선하는 데 필수적입니다. COPD 환자가 2030년 5억 3,200만 명에서 2050년에는 5억 9,200만 명으로 증가할 것으로 예측했습니다.

정량 흡입기 시장의 주요 기업은 약물 전달 효율을 높이고 환자의 어드히어런스를 향상시키기 위해 가압식 정량 흡입기(pMDI)와 같은 첨단 기술 개발에 주력하고 있습니다. pMDI는 가압된 추진제를 사용하여 에어로졸의 형태로 특정량의 약물을 방출하는 장치입니다. 예를 들어, 2023년 7월 인도 제약 회사 Lupin Limited는 성인 천식과 만성 폐색성 폐질환(COPD)을 치료하기 위한 pMDI인 Luforbec 100/6을 독일에서 출시했습니다. 이 흡입기는 100 ㎍의 베크로메타손과 6 ㎍의 포르모테롤을 배합하여 환자에게 효과적인 병용 요법을 제공합니다. 주목할만한 것은 Luforbec의 가격이 고정 기준 가격보다 약 47% 낮고 합리적인 가격입니다. 독일에서는 성인의 약 5%가 천식을 앓고 있기 때문에 이번 발매는 중대한 헬스케어 수요를 충족하고 호흡기 케어의 결과를 개선하기 위한 Lupin의 헌신을 강조하는 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Metered dose inhalers (MDIs) are medical devices that deliver a specific amount of aerosolized medication directly into the lungs through inhalation. These inhalers are widely used to manage respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and various other lung diseases.

There are several types of metered dose inhaler devices, including desktop metered dose inhalers, portable metered dose inhalers, and others. Desktop metered dose inhalers are fixed devices primarily found in clinical environments, providing a controlled dose of aerosolized medication. These devices are available through both online and offline distribution channels and are commonly used for conditions such as asthma and COPD. They serve a range of end users, including hospitals, clinics, homecare settings, and more.

The metered dose inhaler devices market research report is one of a series of new reports from The Business Research Company that provides metered dose inhaler devices market statistics, including metered dose inhaler devices industry global market size, regional shares, competitors with a metered dose inhaler devices market share, detailed metered dose inhaler devices market segments, market trends and opportunities, and any further data you may need to thrive in the metered dose inhaler devices industry. This metered dose inhaler devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metered dose inhaler devices market size has grown strongly in recent years. It will grow from $15.46 billion in 2024 to $16.36 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historical period can be attributed to the rising prevalence of diabetes, a higher demand for metered dose inhaler devices, an increase in the number of metered dose inhaler devices, and a growing incidence of chronic obstructive pulmonary disease (COPD).

The metered dose inhaler devices market size is expected to see strong growth in the next few years. It will grow to $20.29 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth during the forecast period can be driven by the growing prevalence of chronic obstructive pulmonary diseases (COPD), the rising incidence of asthma, an increase in infectious diseases, a higher rate of diabetes, and a rise in respiratory diseases. Key trends expected in the forecast period include technological advancements, the development of innovative therapies, regulatory approvals, the introduction of new inhalers, and the widespread use of online marketing tools.

The growing prevalence of chronic obstructive pulmonary diseases (COPD) is expected to drive the expansion of the metered dose inhaler (MDI) devices market. COPD is a progressive lung condition marked by airflow restriction, usually caused by prolonged exposure to irritants such as cigarette smoke, and leads to symptoms such as shortness of breath, coughing, and wheezing. The rise in COPD cases can be attributed to factors such as tobacco consumption, air pollution, an aging population, and delayed diagnosis or treatment. MDI devices are vital in managing COPD by delivering medication directly to the lungs, offering rapid relief and improving airflow. For example, in December 2023, the National Institutes of Health, a US-based government agency, projected that COPD cases would increase from 532 million in 2030 to 592 million by 2050. Consequently, the growing prevalence of COPD is fueling the demand for metered dose inhaler devices.

Leading companies in the metered dose inhaler devices market are concentrating on developing advanced technologies, such as pressurized metered dose inhalers (pMDIs), to boost medication delivery efficiency and increase patient adherence. pMDIs are devices that release a specific dose of medication in aerosol form using a pressurized propellant. For example, in July 2023, Lupin Limited, an India-based pharmaceutical company, introduced Luforbec 100/6, a pMDI aimed at treating adult asthma and chronic obstructive pulmonary disease (COPD) in Germany. This inhaler combines 100 µg of beclometasone and 6 µg of formoterol, offering an effective combination therapy for patients. Notably, Luforbec is priced around 47% below the fixed reference price, making it more affordable. Given that approximately 5% of adults in Germany suffer from asthma, this launch highlights Lupin's dedication to meeting significant healthcare demands and improving respiratory care outcomes.

In March 2022, R-V Industries, Inc., a US-based manufacturer of industrial equipment, acquired MBC Aerosol Inc. for an undisclosed sum. This acquisition is intended to strengthen R-V Industries' aerosol processing and packaging capabilities, broaden its operations beyond Pennsylvania, and support its growth strategy through acquisitions, ensuring greater stability and efficiency across multiple industries. MBC Aerosol Inc. is a US-based manufacturer specializing in the production of metered dose inhalers (MDIs).

Major players in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, and Iconovo AB.

North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metered dose inhaler devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the metered dose inhaler devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metered dose inhaler devices market consists of sales of products including bronchodilators, corticosteroids, combination inhalers, and anticholinergics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metered Dose Inhaler Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metered dose inhaler devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for metered dose inhaler devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metered dose inhaler devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Metered Dose Inhaler Devices Market Characteristics

3. Metered Dose Inhaler Devices Market Trends And Strategies

4. Metered Dose Inhaler Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Metered Dose Inhaler Devices Growth Analysis And Strategic Analysis Framework

6. Metered Dose Inhaler Devices Market Segmentation

7. Metered Dose Inhaler Devices Market Regional And Country Analysis

8. Asia-Pacific Metered Dose Inhaler Devices Market

9. China Metered Dose Inhaler Devices Market

10. India Metered Dose Inhaler Devices Market

11. Japan Metered Dose Inhaler Devices Market

12. Australia Metered Dose Inhaler Devices Market

13. Indonesia Metered Dose Inhaler Devices Market

14. South Korea Metered Dose Inhaler Devices Market

15. Western Europe Metered Dose Inhaler Devices Market

16. UK Metered Dose Inhaler Devices Market

17. Germany Metered Dose Inhaler Devices Market

18. France Metered Dose Inhaler Devices Market

19. Italy Metered Dose Inhaler Devices Market

20. Spain Metered Dose Inhaler Devices Market

21. Eastern Europe Metered Dose Inhaler Devices Market

22. Russia Metered Dose Inhaler Devices Market

23. North America Metered Dose Inhaler Devices Market

24. USA Metered Dose Inhaler Devices Market

25. Canada Metered Dose Inhaler Devices Market

26. South America Metered Dose Inhaler Devices Market

27. Brazil Metered Dose Inhaler Devices Market

28. Middle East Metered Dose Inhaler Devices Market

29. Africa Metered Dose Inhaler Devices Market

30. Metered Dose Inhaler Devices Market Competitive Landscape And Company Profiles

31. Metered Dose Inhaler Devices Market Other Major And Innovative Companies

32. Global Metered Dose Inhaler Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metered Dose Inhaler Devices Market

34. Recent Developments In The Metered Dose Inhaler Devices Market

35. Metered Dose Inhaler Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기